The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1-Infected Patients

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	36-39
Number of pages	4
Journal	Jaids. Journal of Acquired Immune Deficiency Syndromes
Volume	68
Issue number	1
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3452df71a0b64eb7a9955d3128ec05e1,

title = "The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1-Infected Patients",

author = "Casper Rokx and M Blonk and Annelies Verbon and D Burger and Bart Rijnders",

year = "2015",

language = "Undefined/Unknown",

volume = "68",

pages = "36--39",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

number = "1",

}

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Efficacy, Pharmacokinetics, and Safety of a Nevirapine to Rilpivirine Switch in Virologically Suppressed HIV-1-Infected Patients

AU - Rokx, Casper

AU - Blonk, M

AU - Verbon, Annelies

AU - Burger, D

AU - Rijnders, Bart

PY - 2015

Y1 - 2015

M3 - Article

VL - 68

SP - 36

EP - 39

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -